Resultados de la búsqueda 431-440 of 4011 for Atypical

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    After enrollment, patients will receive one cycle of Induction chemotherapy. Subsequent therapy will be based upon MIBG avidity and ALK status. Patients with ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  3. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    The overall objective of this study is to define genes causing cystic kidney disease and to determine the degree to which variants at these cystic kidney ...

  4. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate a low-cost Contrast Enhanced Digital Mammogram (CEDM) protocol as a supplemental screening method to standard ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma (MelMarT). Scottsdale/Phoenix, Ariz. The purpose of ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Giving capecitabine and temozolomide after surgery could prevent or delay the return of cancer in patients with high-risk well-differentiated pancreatic ...

  7. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The natural course of autosomal dominant polycystic kidney disease (ADPKD) is highly variable and typically characterized by progressive ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is evaluate the safety of allogeneic adipose derived mesenchymal stem cell (AMSC) use during hemodialysis arteriovenous fistula ...

  9. Centros vasculares - Ensayos clínicos - Mayo Clinic

    We aim to determine whether cognitive impairment attributable to cerebral hemodynamic impairment in patients with high-grade asymptomatic carotid artery ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...